TMED3通过FOXO1a和FOXO3a酸化促进前列腺癌
Xiuwang Wei1, Jianbo Liang1, Huanwen Huang1
1Department of Urology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530000, China.
Oncology research
|December 30, 2024
概括
通过影响FOXO1a和FOXO3a酸化,促进了前列腺癌的进展. 抑制TMED3可能为前列腺癌治疗提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 跨膜EMP24贩运蛋白3 (TMED3) 涉及到各种瘤.
- 它在前列腺癌进展中的作用尚不清楚.
研究的目的:
- 为了研究TMED3在前列腺癌中的功能.
- 阐明涉及FOXO通路的潜在分子机制.
主要方法:
- 在前列腺癌细胞 (DU145) 和小鼠模型中使用短毛RNA (shRNA) 抑制TMED3.
- 进行了体外和体内实验.
- 基因和基因组的京都百科全书 (KEGG) 途径分析进行.
主要成果:
- 在前列腺癌细胞中,TMED3表达升高.
- 抑制TMED3减少了扩散,入侵和迁移,同时增加了DU145细胞中的亡.
- 在体内通过FOXO1a和FOXO3a酸化抑制了TMED3下调的瘤生长,亡和转移.
结论:
- TMED3通过FOXO1a和FOXO3a酸化来调节前列腺癌的进展.
- TMED3抑制为前列腺癌提供了一个潜在的新疗法策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Master Transcription Regulators
6.7K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.7K
The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K


